During the past decade, Centro Internacional de Pesquisa; Reumatologia conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centro Internacional de Pesquisa; Reumatologia" #1 collaborator was "Roche Pharma AG" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Centro Internacional de Pesquisa; Reumatologia" are "Rheumatoid Arthritis" (2 trials). Many other conditions were trialed in "Centro Internacional de Pesquisa; Reumatologia" in a lesser frequency.

Most popular intervention types in "Centro Internacional de Pesquisa; Reumatologia" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Methotrexate" (2 trials), "Leflunomide" (1 trials), "Ocrelizumab" (1 trials), "Placebo" (1 trials) and "Placebo to methotrexate" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centro Internacional de Pesquisa; Reumatologia" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Centro Internacional de Pesquisa; Reumatologia". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Centro Internacional de Pesquisa; Reumatologia, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Centro Internacional de Pesquisa; Reumatologia, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".